Register here:
us06web.zoom.us/meeting/regi...
Register here:
us06web.zoom.us/meeting/regi...
#cureMAPTFTD #FTD
us06web.zoom.us/meeting/regi...
#cureMAPTFTD #FTD
us06web.zoom.us/meeting/regi...
No roadmap, limited support, no recognition. The person with FTD may believe, “nothing is wrong”. Others may even blame the carer.
🌎 Learn more: https://bit.ly/3JIO6u0
No roadmap, limited support, no recognition. The person with FTD may believe, “nothing is wrong”. Others may even blame the carer.
🌎 Learn more: https://bit.ly/3JIO6u0
Almost everyone with the gene will develop symptoms (full penetrance), usually between ages 40-60. In rare cases, onset can be later or never happen at all
Almost everyone with the gene will develop symptoms (full penetrance), usually between ages 40-60. In rare cases, onset can be later or never happen at all
MAPT → Changes personality first. Loss of social skills, repetitive behaviors.
GRN → Often causes depression/anxiety first, plus movement problems. May affect speech.
C9orf72 → Often overlaps with ALS, causing apathy and memory impairment.
MAPT → Changes personality first. Loss of social skills, repetitive behaviors.
GRN → Often causes depression/anxiety first, plus movement problems. May affect speech.
C9orf72 → Often overlaps with ALS, causing apathy and memory impairment.
www.standupforscience.net/bethesda-dec...
www.standupforscience.net/bethesda-dec...
ftdregistry.org/press/inside...
ftdregistry.org/press/inside...
Time: 2:30 EST / 11:30 PST
RSVP here:
addcal.io/e/8dvuabbn7why
Time: 2:30 EST / 11:30 PST
RSVP here:
addcal.io/e/8dvuabbn7why
@theaftd.bsky.social
#curemaptftd #maptftd #ftd
@theaftd.bsky.social
#curemaptftd #maptftd #ftd
Listen to the podcast here: news.wjct.org/show/whats-h...
Available now on all podcast streaming platforms!
#curemaptftd #maptftd #npr #nprpodcast #ftd
Listen to the podcast here: news.wjct.org/show/whats-h...
Available now on all podcast streaming platforms!
#curemaptftd #maptftd #npr #nprpodcast #ftd
Listen in on a moving conversation on resilience as we fight with her and so many others against genetic destiny🧬🧠
npr.org/podcasts/103...
Listen in on a moving conversation on resilience as we fight with her and so many others against genetic destiny🧬🧠
npr.org/podcasts/103...
With so many great tau researchers like @leatgrinberg.bsky.social @lucbuee.bsky.social @sjorsscheres.bsky.social @selinawray.bsky.social @karchlab.bsky.social on #SciSky could not help but put together my 1st starterpack⤵️
We are all fighting for you @curemaptftd.bsky.social 💙
go.bsky.app/KHno2VG
With so many great tau researchers like @leatgrinberg.bsky.social @lucbuee.bsky.social @sjorsscheres.bsky.social @selinawray.bsky.social @karchlab.bsky.social on #SciSky could not help but put together my 1st starterpack⤵️
We are all fighting for you @curemaptftd.bsky.social 💙
go.bsky.app/KHno2VG
Hello BlueSky. One of our cofounders, Linde Jacobs, is profiled in The New York Times today. It’s a moving snapshot of what an FTD family goes through. Help us fight for therapies that can cure dementia for under 60s. #ftd #aftd #dementia #tau #alzheimers #mapt
www.nytimes.com/2024/12/22/h...
NYT | zurl.co/hDdSP
NYT | zurl.co/hDdSP
Hello BlueSky. One of our cofounders, Linde Jacobs, is profiled in The New York Times today. It’s a moving snapshot of what an FTD family goes through. Help us fight for therapies that can cure dementia for under 60s. #ftd #aftd #dementia #tau #alzheimers #mapt
www.nytimes.com/2024/12/22/h...
Hello BlueSky. One of our cofounders, Linde Jacobs, is profiled in The New York Times today. It’s a moving snapshot of what an FTD family goes through. Help us fight for therapies that can cure dementia for under 60s. #ftd #aftd #dementia #tau #alzheimers #mapt
www.nytimes.com/2024/12/22/h...